Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Medtronic doc hire: Martin Rothman will join the company Jan. 4 as VP of medical affairs for Medtronic's Santa Clara, Calif., coronary and peripheral vascular business. Rothman is an interventional cardiologist from the United Kingdom, where he spent 27 years at the London Chest Hospital

You may also be interested in...



People In Brief

Biotronik CRM: Veteran Medtronic cardiac rhythm management unit executive Patrick L. Horan joins Biotronik May 14 as VP of corporate sales for U.S. operations, where he will help drive sales for implantable cardioverter defibrillators and pacemakers. The Berlin-based cardiovascular device company has increased efforts in the past several years to push into the U.S. CRM market, still dominated by Medtronic, Boston Scientific and St. Jude Medical. Horan left Medtronic last year and briefly went to surgical device firm Synovis Life Technologies before joining Biotronik. Horan has also been active in the group purchasing organization community as a board member of the Health Industry Group Purchasing Association (1"The Gray Sheet" Dec. 14, 2009)

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028279

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel